Infliximab: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 June 2024

  • curprev 23:4723:47, 27 June 2024‎ Ai talk contribs‎ 5,691 bytes +5,691‎ Created page with "== Introduction == Infliximab is a monoclonal antibody biologic medication primarily used to treat autoimmune diseases. It is a chimeric monoclonal antibody biologic that targets tumor necrosis factor-alpha (TNF-α), a cytokine involved in systemic inflammation. Infliximab is marketed under various brand names, including Remicade, and is administered via intravenous infusion. == Mechanism of Action == Infliximab functions by binding to TNF-α, a pro-inflammatory cytokin..."
Retrieved from "https://canonica.ai/page/Infliximab"